Article Details
Retrieved on: 2025-02-21 16:15:47
Tags for this article:
Click the tags to see associated articles and topics
Summary
Sortera Bio, a Cambridge-based spinout involving Philipp Holliger and AstraZeneca, utilizes generative AI models in its Deep Screening technology for rapid drug discovery. The initiative underscores innovation via cross-sector collaboration.
Article found on: www2.mrc-lmb.cam.ac.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here